Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity ...
A 52% increase from baseline in mean C-peptide AUC at Week 12 in patients diagnosed within 0–3 years (n=5) receiving ...
It’s a bad choice between two phonies running disreputable campaigns, but we can at least hope that after the campaign Kim ...
BEIJING -- A Chinese research team has announced a key breakthrough in the space-based gravitational wave detection program ...
UNC has officially opened a new office in Washington, D.C., which the university is dubbing "Carolina in the Capital." ...
Endocrine therapy is one of the top predictors of sexual dysfunction in women cancer survivors, according to a study shown at ...
Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
From cutting grass to computer programming, the creator of PCS Software is back with a new, cloud-native TMS designed with ...
As pharmaceutical companies push changes to the 340B drug pricing program, safety-net hospitals serving Black and low-income ...
Standard road tests aren't enough in the courtroom. Learn how Bison Transport uses data-driven cognitive screening to ...
The new CI-Fortify initiative urges critical infrastructure operators to prepare for cyberattacks by ensuring they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results